+390677209020 | +39 0267380552 info@direnzo.biz | sedemilano@direnzo.biz

Lingua

Farmacovigilanza sui social network

Pharmacovigilance in the Social Networks

Pharmacovigilance consists in a set of activities to identify, assess, understand and prevent adverse events or any other issue related...

Serialisation and traceability, the fight against counterfeiting continues

On 9 February 2019 Directive 2011/62/EU of the European Parliament and of the Council amending Directive 2001/83/EC, on the Community...

Sostanze erbali nei dispositivi medici

Herbals in medical devices: how to manage your products with MDCG 2022-5

In April 2022, the awaited guideline on borderline devices was published pursuant to Regulation 2017/745. The document MDCG 2022-5, “Guidance...

Medical devices authorisations by way of derogation

On 16 February 2023, the Ministry of Health has published the memorandum letter “Operating Procedures for the Application of Authorisation...

eudamed

The role of the European database “EUDAMED” and its functions for clinical trials

An essential aspect to reach the goals of Regulation EU 2017/745 on medical devices is the implementation of the European...

Medical device vigilance

The reference regulations on medical devices and active implantable medical devices (MDs) establish that all manufacturers, or their authorised representatives,...

Carenza dispositivi medici

Medical device pay-back, latest news

Law-Decree 11 January 2023 no. 4 was published in the Italian Official Journal no. 8. This provides for a time...

Change of the MDR and IVDR transitory period: where are we?

On 6 January 2023 the European Commission has adopted a proposal to change the provisions regarding the transitory period for...

Meddra

The globalisation of pharmaceutical terms (MedDRA)

We all know how it is important today to keep up with the times in either personal or working fields,...